Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: JT's PR was followed by the SEC filing... S402005

Nothing new due to the fact that this information was published with the relevant SEC-filings!

 

The last relevant SEC filing was the 10K, in which, Common stock held in treasury, at cost - 13,467,527 shares at May 31, 2007. "To date(September 17, 2007)we’ve acquired more than 18 million of our own shares..."

 

Be well 

Share
New Message
Please login to post a reply